XPENG Invited to CVPR for the Third Time, Showcasing China's Advances in Physical AI to the World
DENVER, June 4, 2026 /PRNewswire/ -- XPENG (NYSE: XPEV, HKEX: 9868), a leading China-based high-tech company, kicks off its key presence at CVPR 2026 (The IEEE/CVF Conference on Computer Vision and Pattern Recognition). Dr. Xianming Liu, Head of...
Grit Biotherapeutics Invited to Deliver Oral Presentation at ASH 2025 on Breakthrough In Vivo CAR-T Therapy GT801
BEIJING, Nov. 4, 2025 /PRNewswire/ -- Grit Biotherapeutics Co., Ltd. ("Grit Bio"), a leading clinical-stage biopharmaceutical company pioneering next-generation immunotherapies, today announced that its groundbreaking GT801 in vivo CAR-T program has...